Friday, December 4, 2009

Lilly: FDA OKs Zyprexa For Schizophrenia In Teens; New Label - CNNMoney.com


Lilly: FDA OKs Zyprexa For Schizophrenia In Teens; New Label
CNNMoney.com
... problems such as diabetes and cardiovascular disease. Lilly's shares rose 1.3% to $37.88 in after-hours trading. The stock has gained 10% in the past year.

and more »

No comments:

Post a Comment